V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20193371 | 20124272 | 1.63 | 80 | null | 2017-03-07 | 2017-03-09 | Docetaxel | 02 | null | DOCETAXEL | 101488770 |
| 20193375 | 20124273 | 1.6 | 65.5 | Adjuvant (A) | 2020-01-10 | 2020-01-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101196253 |
| 20193379 | 20124274 | 1.89 | 88.3 | Palliative (P) | 2019-09-17 | 2019-09-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100161114 |
| 20193380 | 20124275 | 1.67 | 70 | Palliative (P) | 2016-09-21 | 2016-10-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100900480 |
| 20193383 | 20124276 | 1.76 | 68.8 | null | 2017-03-27 | 2017-04-03 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101400076 |
| 20193385 | 20124277 | 1.63 | 61.5 | Palliative (P) | 2019-08-30 | 2019-08-30 | Docetaxel | 02 | N | DOCETAXEL | 100361583 |
| 20193386 | 20124278 | null | 97.6 | Palliative (P) | 2018-05-30 | 2018-09-26 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101124524 |
| 20193387 | 20124279 | 1.59 | 47.6 | Palliative (P) | 2019-04-05 | 2019-04-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100166024 |
| 20193391 | 20124280 | 1.84 | 71.5 | Palliative (P) | 2019-08-02 | 2019-08-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101240163 |
| 20193393 | 20124281 | 1.66 | 57.5 | Adjuvant (A) | 2019-04-16 | 2019-04-23 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100612370 |
| 20193395 | 20124282 | 1.7 | 76 | null | 2016-08-09 | 2016-08-12 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100194310 |
| 20193396 | 20124283 | 1.7 | 67.9 | null | 2018-05-19 | 2018-06-04 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101854398 |
| 20193405 | 20124284 | 1.55 | 100 | Palliative (P) | 2019-02-18 | 2019-02-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101146754 |
| 20193407 | 20124285 | null | 76.9 | null | 2019-09-15 | 2019-10-10 | Cetuximab + FOLFIRI cycle1 | N | null | CAPECITABINE + GEMCITABINE | 101020739 |
| 20193412 | 20124286 | 1.79 | 71.6 | null | 2016-10-17 | 2016-10-31 | Docetaxel 100mg/m2 (21 day) | N | null | DOCETAXEL | 100111699 |
| 20193420 | 20124287 | 1.86 | 75 | Palliative (P) | 2017-09-04 | 2017-09-11 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100748556 |
| 20193422 | 20124288 | 1.9 | 81 | Palliative (P) | 2019-12-06 | 2020-01-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101102216 |
| 20193434 | 20124289 | 1.52 | 54.3 | Palliative (P) | 2019-07-11 | 2019-07-30 | Docetaxel 75mg/m2 (21 day) | null | N | DOCETAXEL | 100260454 |
| 20193437 | 20124290 | 1.6 | 59 | 03 | null | 2017-11-03 | Docetaxel | N | N | DOCETAXEL | 100217917 |
| 20193439 | 20124291 | 1.68 | 76.4 | Palliative (P) | 2021-08-18 | 2021-09-08 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100832115 |
| 20193441 | 20124292 | 1.66 | 85 | Palliative (P) | 2017-08-24 | 2017-08-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101232704 |
| 20193442 | 20124293 | 1.8 | 71 | Palliative (P) | 2017-05-18 | 2017-06-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100413058 |
| 20193445 | 20124294 | 1.76 | 71.4 | null | 2018-12-22 | 2019-08-09 | Gemcitabine + Capecitabine | 2 | null | CAPECITABINE + GEMCITABINE | 101461853 |
| 20193453 | 20124295 | 1.78 | 78.5 | null | 2019-01-22 | 2019-02-03 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100693071 |
| 20193456 | 20124296 | 1.72 | 72.3 | Palliative (P) | 2018-09-14 | 2018-09-21 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100250951 |
| 20193463 | 20124297 | 1.6 | 61.6 | Palliative (P) | 2019-01-08 | 2019-06-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100192414 |
| 20193468 | 20124298 | 1.74 | 61.1 | null | 2016-12-20 | 2016-12-20 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100466218 |
| 20193469 | 20124299 | 1.85 | 86.3 | null | 2016-05-04 | 2016-05-12 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100020762 |
| 20193470 | 20124300 | 1.8 | 78 | null | 2019-09-15 | 2019-09-30 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101418875 |
| 20193476 | 20124301 | 1.62 | null | Palliative (P) | 2016-08-13 | 2016-09-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100552441 |
| 20193477 | 20124302 | 1.69 | 56.7 | Palliative (P) | 2016-06-02 | 2016-07-13 | Docetaxel | 02 | N | DOCETAXEL | 100098998 |
| 20193480 | 20124303 | 1.68 | 39.2 | Palliative (P) | 2018-07-16 | 2019-03-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101662850 |
| 20193481 | 20124304 | 1.66 | 58 | Palliative (P) | 2019-02-10 | 2019-02-10 | Docetaxel | 02 | N | DOCETAXEL | 100956552 |
| 20193489 | 20124305 | 1.84 | 63.6 | Palliative (P) | 2018-11-23 | 2018-11-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101513260 |
| 20193491 | 20124306 | 1.51 | 59.2 | Palliative (P) | 2019-01-10 | 2019-01-10 | Docetaxel | N | N | DOCETAXEL | 101698535 |
| 20193493 | 20124307 | 1.63 | 71.8 | Palliative (P) | 2016-06-13 | 2017-02-28 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100536515 |
| 20193494 | 20124308 | 1.55 | 54.8 | null | 2020-08-22 | 2020-09-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101779284 |
| 20193496 | 20124309 | 1.66 | 66 | Palliative (P) | 2016-04-07 | 2016-08-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101653559 |
| 20193497 | 20124310 | 1.55 | 40 | Palliative (P) | 2017-10-18 | 2017-10-18 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 101200399 |
| 20193500 | 20124311 | 1.67 | 98 | null | 2017-09-07 | 2017-09-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101032457 |
| 20193501 | 20124312 | 1.74 | 46.2 | Palliative (P) | 2015-12-30 | 2016-12-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100550566 |
| 20193505 | 20124313 | null | 56.5 | Palliative (P) | 2017-10-26 | 2017-11-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100343472 |
| 20193508 | 20124314 | 1.6 | 94.2 | Neo-adjuvant (N) | 2018-02-08 | 2018-03-09 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101645955 |
| 20193511 | 20124315 | 1.83 | 78 | Palliative (P) | 2018-07-16 | 2018-07-18 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100328319 |
| 20193513 | 20124316 | 1.6 | 52 | Palliative (P) | 2018-12-27 | 2019-01-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100563703 |
| 20193515 | 20124317 | 1.54 | 110.9 | Palliative (P) | 2019-07-05 | 2019-07-19 | Docetaxel | 02 | N | DOCETAXEL | 101810681 |
| 20193518 | 20124318 | 1.63 | 95.8 | null | 2019-06-15 | 2019-06-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 100391994 |
| 20193521 | 20124319 | 1.74 | 43.2 | Palliative (P) | 2019-06-07 | 2019-06-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101781546 |
| 20193526 | 20124320 | 1.76 | 44 | Neo-adjuvant (N) | 2017-12-16 | 2017-12-16 | Docetaxel | 02 | N | DOCETAXEL | 100618817 |
| 20193527 | 20124321 | 1.72 | 82.1 | Palliative (P) | 2019-10-12 | 2019-10-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101871433 |